Reduces Nrf2 expression through down-regulation of PI3K/Akt pathway [67]Sensitizes tumor xenografts to doxorubicin [67]Induces glutathione depletion [94] and inhibits mitochondrial complex I activity in rats [151]. The gene discussed is NFE2L2; the disease is neoplasm.